The prevalence of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is rapidly increasing worldwide, affecting an estimated 6.8 million people.
The prevalence of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is rapidly increasing worldwide, affecting an estimated 6.8 million people.